Press release article from our research archive:

AAOMS Issues Prevention and Management Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).

ROSEMONT, Ill., Oct. 3 /PRNewswire/ -- In 2003 and 2004, oral and maxillofacial surgeons recognized and reported an increased number of cases of osteonecrosis of the jaw, characterized by non-healing, exposed bone, in the maxillofacial area of patients treated with intravenous and oral bisphosphonates. Bisphosphonates are a recognized and effective class of drugs used intravenously to help cancer patients and in oral form for patients with osteopenia and osteoporosis.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050125/CGTU021LOGO )

Noting that a patient's risk of developing Bisphosphonate-Related Osteonecrosis of the Jaw, or BRONJ, may be affected by the ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!